Results 31 to 40 of about 22,301 (176)

Meningococcus this Winter : what was going on? [PDF]

open access: yes, 1996
There was a time in the not very distant past when meningococcus was not being recognised locally. While laboratory sensitivity used to isolate Neisseria meningitidis has not changed in Malta, the frequency of its detection has increased, more so in the ...
Falzon, Dennis
core  

Teenagers’ understandings of and attitudes towards vaccines and vaccine-preventable diseases: a qualitative study [PDF]

open access: yes, 2013
<p>Background: To examine immunisation information needs of teenagers we explored understandings of vaccination and vaccine-preventable diseases, attitudes towards immunisation and experiences of immunisation.
Barbour   +48 more
core   +1 more source

Toll‐like receptor expression during inflammatory processes in human diseases

open access: yesRheumatology &Autoimmunity, Volume 5, Issue 1, Page 1-14, March 2025.
Chronic inflammation in different illnesses triggered by pathogen‐associated molecular patterns and damage associated molecular patterns recognized by Toll‐like receptors (TLRs). Abstract Multi‐cellular organisms, including humans, have evolved immune systems as defense mechanisms against pathogens. The immune system employs the Toll‐like receptor (TLR)
Prashant K. Dhakad   +2 more
wiley   +1 more source

Epidemic Meningococcal Meningitis, Cameroon

open access: yesEmerging Infectious Diseases, 2011
To the Editor: In 2010, the city of Ngaoundere in Cameroon experienced its first reported epidemic of meningococcal meningitis. Ngaoundere, with an estimated population of 180,000, is the main city in the Adamaoua region in northern Cameroon. The 2 northernmost regions of Cameroon, North and Far North, are considered to belong to the African meningitis
H. Hamadicko   +3 more
openaire   +4 more sources

A review of acute bacterial meningitis in childhood [PDF]

open access: yes, 1996
This paper reviews the epidemiology, pathogenesis and management of acute bacterial meningitis in childhood. The epidemiology of this infection has undergone significant changes with the implementation of effective immunisation, antibiotic therapy and ...
Muscat Baron, Astrid, Muscat Baron, Yves
core  

A Case of Atypical Hemolytic Uremic Syndrome With a Complement Factor I Mutation Triggered by a Femoral Neck Fracture

open access: yesNephrology, Volume 30, Issue 3, March 2025.
ABSTRACT Atypical hemolytic uremic syndrome is a thrombotic microangiopathy caused by the abnormal activation of the alternative complement pathway. Mutations in complement‐related genes and autoantibodies against complement regulators are involved in the pathogenesis of this condition; the frequency of, and prognosis of patients harbouring, each ...
Toshiki Kano   +8 more
wiley   +1 more source

Systemic manifestations in the course of meningococcal disease [PDF]

open access: yes, 2009
Background/Aim. Meningococcal disease most often manifests itself as meningitis or sepsis. During the course of these diseases, other clinical events sometimes develop such as pneumonia, pericarditis, arthritis, and they are referred to as extrameningeal
Dokić Ljubiša   +7 more
core   +1 more source

The complement system: A key player in the host response to infections

open access: yesEuropean Journal of Immunology, Volume 54, Issue 11, November 2024.
Duality of the complement system during infection: An adequate immune defense clears the infection and restores tissue resilience, whereas a maladaptive response due to complement hyperactivation results in hyperinflammation and tissue injury, as seen in sepsis and pneumonia.
Archana Jayaraman   +2 more
wiley   +1 more source

Meningococcal carriage in the African meningitis belt. [PDF]

open access: yes, 2013
A meningococcal serogroup A polysaccharide/tetanus toxoid conjugate vaccine (PsA-TT) (MenAfriVac(™) ) is being deployed in countries of the African meningitis belt.
MenAfriCar Consortium
core   +1 more source

Insufficient evidence for an association between iatrogenic Alzheimer's disease and cadaveric pituitary‐derived growth hormone

open access: yesAlzheimer's &Dementia, Volume 20, Issue 10, Page 7399-7402, October 2024.
Abstract A Nature Medicine paper published in January 2024 describes eight cases of iatrogenic Alzheimer's disease in individuals who received cadaveric pituitary‐derived human growth hormone. The paper's conclusions argue for the transmissibility of Alzheimer's disease, which, if true, would create a significant public health crisis.
Avi Nath   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy